104 related articles for article (PubMed ID: 8735848)
1. 5'-linked lipid-oligodeoxyridonucleotide derivatives as inhibitors of human immunodeficiency virus replication.
Kim SG; Nakashima H; Shoji Y; Inagawa T; Yamamoto N; Kinzuka Y; Takai K; Takaku H
Bioorg Med Chem; 1996 Apr; 4(4):603-8. PubMed ID: 8735848
[TBL] [Abstract][Full Text] [Related]
2. Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides.
Andreola ML; Calmels C; Michel J; Toulmé JJ; Litvak S
Eur J Biochem; 2000 Aug; 267(16):5032-40. PubMed ID: 10931185
[TBL] [Abstract][Full Text] [Related]
3. Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture.
Letsinger RL; Zhang GR; Sun DK; Ikeuchi T; Sarin PS
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6553-6. PubMed ID: 2771942
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of inhibition of HIV-1 infection in vitro by guanine-rich oligonucleotides modified at the 5' terminal by dimethoxytrityl residue.
Furukawa H; Momota K; Agatsuma T; Yamamoto I; Kimura S; Shimada K
Nucleic Acids Res; 1994 Dec; 22(25):5621-7. PubMed ID: 7530843
[TBL] [Abstract][Full Text] [Related]
5. Phosphorothioate analogues of oligodeoxyribonucleotide: synthesis and activity as inhibitors of replication of human immunodeficiency virus.
Kim SG; Suzuki Y; Nakashima H; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1991 Sep; 179(3):1614-9. PubMed ID: 1930201
[TBL] [Abstract][Full Text] [Related]
6. Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells.
Bordier B; Perala-Heape M; Degols G; Lebleu B; Litvak S; Sarih-Cottin L; Hélène C
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9383-7. PubMed ID: 7568137
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides.
Leiter JM; Agrawal S; Palese P; Zamecnik PC
Proc Natl Acad Sci U S A; 1990 May; 87(9):3430-4. PubMed ID: 2333292
[TBL] [Abstract][Full Text] [Related]
8. Properties of quadruplex oligonucleotides with anti-HIV-1 activity.
Tamura Y; Yoshida M; Suzuki J; Hiratou T; Miyano-Kurosaki N; Takai K; Takaku H
Nucleic Acids Symp Ser; 2000; (44):181-2. PubMed ID: 12903328
[TBL] [Abstract][Full Text] [Related]
9. DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity.
Andreola ML; Pileur F; Calmels C; Ventura M; Tarrago-Litvak L; Toulmé JJ; Litvak S
Biochemistry; 2001 Aug; 40(34):10087-94. PubMed ID: 11513587
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).
Matsukura M; Zon G; Shinozuka K; Stein CA; Mitsuya H; Cohen JS; Broder S
Gene; 1988 Dec; 72(1-2):343-7. PubMed ID: 3243433
[TBL] [Abstract][Full Text] [Related]
11. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Gao HQ; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model.
Inagawa T; Nakashima H; Karwowski B; Guga P; Stec WJ; Takeuchi H; Takaku H
FEBS Lett; 2002 Sep; 528(1-3):48-52. PubMed ID: 12297278
[TBL] [Abstract][Full Text] [Related]
13. Phosphorothioate oligonucleotides block reverse transcription by the Rnase H activity associated with the HIV-1 polymerase.
Hatta T; Takai K; Yokoyama S; Nakashima H; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1995 Jun; 211(3):1041-6. PubMed ID: 7541196
[TBL] [Abstract][Full Text] [Related]
14. Specific inhibition of in vitro reverse transcription using antisense oligonucleotides targeted to the TAR regions of HIV-1 and HIV-2.
Boulme F; Perälä-Heape M; Sarih-Cottin L; Litvak S
Biochim Biophys Acta; 1997 Apr; 1351(3):249-55. PubMed ID: 9130587
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms.
Zelphati O; Imbach JL; Signoret N; Zon G; Rayner B; Leserman L
Nucleic Acids Res; 1994 Oct; 22(20):4307-14. PubMed ID: 7524038
[TBL] [Abstract][Full Text] [Related]
16. CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.
Schlaepfer E; Audigé A; von Beust B; Manolova V; Weber M; Joller H; Bachmann MF; Kundig TM; Speck RF
J Virol; 2004 Nov; 78(22):12344-54. PubMed ID: 15507621
[TBL] [Abstract][Full Text] [Related]
17. Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?
Lavigne C; Yelle J; Sauve G; Thierry AR
AAPS PharmSci; 2002; 4(2):E9. PubMed ID: 12102618
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 replication by chimeric phosphorothioate oligodeoxynucleotides applied in free solution.
Lund OS; Hansen JE
Intervirology; 1998; 41(2-3):63-8. PubMed ID: 9820839
[TBL] [Abstract][Full Text] [Related]
19. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
[TBL] [Abstract][Full Text] [Related]
20. Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells.
Nakashima H; Shoji Y; Kim SG; Shimada J; Mizushima Y; Ito M; Yamamoto N; Takaku H
Nucleic Acids Res; 1994 Nov; 22(23):5004-10. PubMed ID: 7528375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]